The FDA issued a notice updating instructions for a number of ventilators made by Philips (NYSE:PHG) Respironics.

Philips’ high-current/low energy therapy ensures a potent defibrillation dose, while at the same time, minimizing side effects that may be harmful to a fragile heart. So the HeartStart FR2+ can ...

In this episode, we dive deep into the cutting-edge world of cardiac care with Nick Wilson, Business Leader for Philips Ambulatory Monitoring and Diagnostics. Nick shares his insights on the ...

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX ... The company’s latest technology advancements in diagnostic, interventional and monitoring solutions featured at TCT 2024 include: ...

The company's latest technology advancements in diagnostic, interventional and monitoring solutions featured at TCT 2024 include: Leveraging AI for structural heart disease diagnosis: Philips ...